Case Series: Novel Utilization of Rho-Kinase Inhibitor for the Treatment of Corneal Edema
Author:
Publisher
Ovid Technologies (Wolters Kluwer Health)
Subject
Ophthalmology
Reference6 articles.
1. Morphological changes of human corneal endothelial cells after rho-associated kinase inhibitor eye drop (Ripasudil) administration: a prospective open-label clinical study;Nakagawa;PLoS One.,2015
2. Descemet's stripping without endothelial keratoplasty;Garcerant;Curr Opin Ophthalmol.,2019
3. Corneal endothelial cell migration and proliferation enhanced by rho kinase (ROCK) inhibitors in in vitro and in vivo models;Meekins;Investig Ophthalmol Vis Sci.,2016
4. Descemetorhexis without grafting for Fuchs endothelial dystrophy-supplementation with topical ripasudil;Moloney;Cornea.,2017
5. Use of topical rho kinase inhibitors in the treatment of Fuchs dystrophy after Descemet stripping only;Macsai;Cornea.,2019
Cited by 22 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Laboratory exploration of the use of ripasudil in descemetorhexis with a human ex vivo model;Experimental Eye Research;2024-08
2. Squishy matters – Corneal mechanobiology in health and disease;Progress in Retinal and Eye Research;2024-03
3. Evaluating the efficacy of Rho kinase inhibitor eye drops in the management of corneal edema: A single-center retrospective cohort study;Taiwan Journal of Ophthalmology;2024-01
4. The Role of Rho Kinase Inhibitors in Corneal Diseases;Drug Design, Development and Therapy;2024-01
5. Netarsudil-Associated Reticular Epithelial Edema Directly Influenced by Endothelial Dysfunction in a Post-Endothelial Keratoplasty Patient;Cornea Open;2023-12
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3